164 related articles for article (PubMed ID: 35065881)
21. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
Ohori M; Kattan MW; Koh H; Maru N; Slawin KM; Shariat S; Muramoto M; Reuter VE; Wheeler TM; Scardino PT
J Urol; 2004 May; 171(5):1844-9; discussion 1849. PubMed ID: 15076291
[TBL] [Abstract][Full Text] [Related]
22. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
[TBL] [Abstract][Full Text] [Related]
23. The role of the complexed-to-total prostate-specific antigen ratio in predicting the final pathological stage of clinically localized prostate cancer.
Martínez M; Navarro S; Medina P; Villavicencio H; Rioja L; Solsona E; Estellés A; Aznar J; Jiménez-Cruz JF; España F
Eur Urol; 2003 Jun; 43(6):609-14. PubMed ID: 12767360
[TBL] [Abstract][Full Text] [Related]
24. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.
Martini A; Gupta A; Lewis SC; Cumarasamy S; Haines KG; Briganti A; Montorsi F; Tewari AK
BJU Int; 2018 Dec; 122(6):1025-1033. PubMed ID: 29676063
[TBL] [Abstract][Full Text] [Related]
25. A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging.
Di Trapani E; Luzzago S; Peveri G; Catellani M; Ferro M; Cordima G; Mistretta FA; Bianchi R; Cozzi G; Alessi S; Matei DV; Bagnardi V; Petralia G; Musi G; De Cobelli O
Urol Oncol; 2021 Jul; 39(7):431.e15-431.e22. PubMed ID: 33423938
[TBL] [Abstract][Full Text] [Related]
26. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
[TBL] [Abstract][Full Text] [Related]
27. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.
Palisaar RJ; Graefen M; Karakiewicz PI; Hammerer PG; Huland E; Haese A; Fernandez S; Erbersdobler A; Henke RP; Huland H
Eur Urol; 2002 Feb; 41(2):155-61. PubMed ID: 12074402
[TBL] [Abstract][Full Text] [Related]
28. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
29. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
[TBL] [Abstract][Full Text] [Related]
30. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Aronson WJ; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Terris MK;
Urology; 2003 Apr; 61(4):742-7. PubMed ID: 12670558
[TBL] [Abstract][Full Text] [Related]
31. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
Lee A; Lim J; Gao X; Liu L; Chia SJ
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
[TBL] [Abstract][Full Text] [Related]
32. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
[TBL] [Abstract][Full Text] [Related]
33. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis.
Jeong CW; Jeong SJ; Hong SK; Lee SB; Ku JH; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE
Int J Urol; 2012 Sep; 19(9):846-52. PubMed ID: 22587373
[TBL] [Abstract][Full Text] [Related]
34. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
[TBL] [Abstract][Full Text] [Related]
35. Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: development of a novel pre-biopsy nomogram.
Ohigashi T; Kanao K; Mizuno R; Kikuchi E; Nakashima J; Oya M
Int J Urol; 2010 Mar; 17(3):274-80. PubMed ID: 20148990
[TBL] [Abstract][Full Text] [Related]
36. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
Kattan MW; Eastham JA; Wheeler TM; Maru N; Scardino PT; Erbersdobler A; Graefen M; Huland H; Koh H; Shariat S; Slawin KM; Ohori M
J Urol; 2003 Nov; 170(5):1792-7. PubMed ID: 14532778
[TBL] [Abstract][Full Text] [Related]
37. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Kattan MW; Shariat SF; Andrews B; Zhu K; Canto E; Matsumoto K; Muramoto M; Scardino PT; Ohori M; Wheeler TM; Slawin KM
J Clin Oncol; 2003 Oct; 21(19):3573-9. PubMed ID: 12913106
[TBL] [Abstract][Full Text] [Related]
38. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.
Mjaess G; Peltier A; Roche JB; Lievore E; Lacetera V; Chiacchio G; Beatrici V; Mastroianni R; Simone G; Windisch O; Benamran D; Fourcade A; Nguyen TA; Fournier G; Fiard G; Ploussard G; Roumeguère T; Albisinni S; Diamand R
Eur Urol Focus; 2023 Nov; 9(6):992-999. PubMed ID: 37147167
[TBL] [Abstract][Full Text] [Related]
39. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.
Moussa AS; Kattan MW; Berglund R; Yu C; Fareed K; Jones JS
BJU Int; 2010 Feb; 105(3):352-8. PubMed ID: 19681898
[TBL] [Abstract][Full Text] [Related]
40. The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.
Shen P; Zhao J; Sun G; Chen N; Zhang X; Gui H; Yang Y; Liu J; Shu K; Wang Z; Zeng H
Andrology; 2017 May; 5(3):548-555. PubMed ID: 28409907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]